Next |
home / stock / amph / amph message board
Subject | By | Source | When |
---|---|---|---|
AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITIES$AMPHExcited to share an article about | | mwn | 03/12/2023 9:32:53 PM |
I've bought some $AMPH at $31. Great products | Gentlemen Prefer Bonds | investorshub | 06/29/2022 5:36:36 PM |
$AMPH buy 42.3299 | stocktrademan | investorshub | 04/17/2022 8:52:53 AM |
$AMPH 50/200sma crossed here...Nice bullish sign. | Golden Cross | investorshub | 06/24/2020 10:05:50 PM |
fda approval | atarabih | investorshub | 06/09/2020 10:22:00 AM |
Gearing up for another amazing surprise quarter of | MakeABuck2000 | investorshub | 01/12/2018 6:54:47 PM |
reading my friend, their drug helper going on | mick | investorshub | 11/10/2017 8:23:12 PM |
China has several generic-insulin products already on the market. | DewDiligence | investorshub | 03/18/2017 3:00:55 PM |
Do you see them investing in China to | Phaeton | investorshub | 03/18/2017 12:47:29 PM |
Squeezing up! I love it | Jess070283 | investorshub | 03/17/2017 4:46:36 PM |
Momenta, Sandoz allowed to broaden claims over quality | floblu14 | investorshub | 06/29/2016 4:40:25 PM |
AMPH is not a start-up, but it has | DewDiligence | investorshub | 05/13/2015 9:40:07 PM |
Update on Lovenox patent case: #msg-113632332. | DewDiligence | investorshub | 05/13/2015 9:38:27 PM |
No issue. | Phaeton | investorshub | 12/05/2014 3:52:30 AM |
IT IS 32 MILLION FROM NOW TO END | TREND1 | investorshub | 12/04/2014 5:47:09 PM |
They did give a number for their MANNKIND | Phaeton | investorshub | 12/04/2014 1:40:08 PM |
You just did not hear it .... | TREND1 | investorshub | 12/04/2014 2:42:24 AM |
They did not give any dollar figure for | Phaeton | investorshub | 12/04/2014 2:40:18 AM |
This EPS info is wrong. | TREND1 | investorshub | 12/04/2014 1:19:14 AM |
Phaeton Did you catch only 32 million sales to | TREND1 | investorshub | 12/04/2014 1:17:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank of America Health Care Conference on Wednesday, M...
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2024. First Quarter ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...